Discussion
sexual dysfunction, complaints of urinary symptoms, complaints of sexual activity, pain
This study revealed that male patients comprised more than 70% of the occurrence in both group and the majority (52.84%) in the age of 26-45 years. The findings of this study are comparable with those of Pansota Post-DJ-stent patients who experienced SRSs were divided into 2 groups and treated with Tadalafil 10 mg/day or a combination of mirabegron 25 mg/day + solifenacin 5 mg/day. Both groups were then observed and assessed using the USSQ questionnaire. According to the study's findings, the tadalafil therapy group exceeded the mirabegron and solifenacin combination group in treating all SRSs.The findings of this study suggest that treatment with tadalafil 10 mg/day for three weeks in patients having DJ-stents implanted can lessen complaints of urinary symptoms, pain, complaints of general condition, complaints of working activity, complaints of sexual activity, and other complaints. The most effective treatment for patients following DJ-stent insertion can reduce pain complaints using tadalafil 10 mg/day for three weeks. The findings of this study are consistent with those of Haghro Tadalafil 10 mg in this study can reduce urinary symptoms by 19.08 ± 4.21 points in three weeks. Similar findings were also reported by Bhattar Similar to the efficacy of tadalafil in the present study, the combination of mirabegron 25 mg/day + solifenacin 5 mg/day for three weeks can improve the urinary symptoms, pain, general condition, working activity, and other complaints. However, there was a significant in allegations of sex activity. In a study conducted by Abrams Based on previous studies, researchers have not found a study comparing the effectiveness of tadalafil 10 mg/day and the combination of mirabegron 25 mg/day + solifenacin 5 mg/day in patients with SRSs. The limitations of this study were that some of the samples in this study were sexually inactive such as not having a partner, old age, and a partner died, as well as the uneven timing of starting sexual activity so that it affected the results on the USSQ questionnaire and the duration of observation in this study lasted for 4 weeks so that only can assess the short-term effect of drug administration on complaints of SRSs. There are other several limitations such as a small sample size, and no comparison after stent removal. The variations and bias in the USSQ questionnaire's five parts have a logical correlation to each other; for example, the patients who had stent-related urinary symptoms have more chance for sexual dysfunction, and the patients who had urinary symptoms, pain, and inappropriate general health had bad quality and quantity of job.